[A new antibiotic in the treatment of infections caused by gram positive bacteria: lincomycin. In vitro study and clinical experience].
D000328:Adult; D001982:Bronchial Diseases / Q000188:drug therapy; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use*; D008088:Listeriosis / Q000188:drug therapy*; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D010000:Osteitis / Q000188:drug therapy; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy; D011008:Pneumococcal Infections / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*
D008034:Lincomycin
Un nouvel antibiotique dans le traitement des infections à germes gram positif: la lincomycine. Etude "in vitro" et expérience clinique.